Skip to content

Longevity Health Holdings, Inc.: 10-Q filed 2024-08-14

What Longevity Health Holdings, Inc. reported in its quarterly report filed 2024-08-14 (fiscal Q2 2024): 43 published measures, 119 facts as tagged in accession 0000950170-24-097039.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-14
Fiscal period
fiscal Q2 2024
Accession
0000950170-24-097039 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Longevity Health Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-305,033,855USD
At 2023-12-3163,948,803USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-306,405,627USD
At 2023-12-3139,199,793USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-30-1,371,772USD
At 2024-03-31-1,391,659USD
At 2023-12-3124,749,010USD
At 2023-06-30-45,106,372USD
At 2023-03-31-39,743,801USD
At 2022-12-31-37,790,539USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-302,198,275USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,304,538USD91
2024-01-01 to 2024-06-30-6,575,497USD182
2023-04-01 to 2023-06-30-5,308,952USD91
2023-01-01 to 2023-06-30-7,137,667USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-2,214,254USD182
2023-01-01 to 2023-06-30-956,137USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-06-3030,470USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-04-01 to 2024-06-3012,320USD91
2024-01-01 to 2024-06-3012,320USD182
2023-04-01 to 2023-06-300USD91
2023-01-01 to 2023-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-302,248,864USD182
2023-01-01 to 2023-06-30874,378USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-748,796USD182
2023-01-01 to 2023-06-30-30,470USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-65,078,898USD
At 2023-12-31-58,503,401USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-3020,735,019shares91
2024-01-01 to 2024-06-3021,825,089shares182
2023-04-01 to 2023-06-301,124,601shares91
2023-01-01 to 2023-06-301,126,673shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-3020,735,019shares91
2024-01-01 to 2024-06-3021,825,089shares182
2023-04-01 to 2023-06-301,124,601shares91
2023-01-01 to 2023-06-301,126,673shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.16USD/shares91
2024-01-01 to 2024-06-30-0.3USD/shares182
2023-04-01 to 2023-06-30-5USD/shares91
2023-01-01 to 2023-06-30-6.89USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.16USD/shares91
2024-01-01 to 2024-06-30-0.3USD/shares182
2023-04-01 to 2023-06-30-5USD/shares91
2023-01-01 to 2023-06-30-6.89USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-300USD91
2024-01-01 to 2024-06-300USD182
2023-04-01 to 2023-06-300USD91
2023-01-01 to 2023-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-30148,049USD
At 2023-12-31192,846USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-06-30375,169USD182
2023-01-01 to 2023-06-30367,539USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-1,191,487USD91
2024-01-01 to 2024-06-30-2,571,832USD182
2023-04-01 to 2023-06-30-1,487,384USD91
2023-01-01 to 2023-06-30-2,762,255USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-304,101,006USD
At 2023-12-3162,900,114USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-04-01 to 2024-06-303,264USD91
2024-01-01 to 2024-06-3014,830USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-305,777,678USD
At 2023-12-3138,502,078USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-304,095,418USD
At 2023-12-314,417,234USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2024-06-3021,923USD
At 2023-12-3124,187USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,203,515USD91
2024-01-01 to 2024-06-302,583,860USD182
2023-04-01 to 2023-06-301,487,384USD91
2023-01-01 to 2023-06-302,762,255USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-06-30113,872USD
At 2023-12-310USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-3012,028USD91
2024-01-01 to 2024-06-3012,028USD182
2023-04-01 to 2023-06-300USD91
2023-01-01 to 2023-06-300USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-30104,066USD91
2024-01-01 to 2024-06-30533,486USD182
2023-04-01 to 2023-06-30823,657USD91
2023-01-01 to 2023-06-301,563,982USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3020,905,407shares
At 2023-12-3123,090,585shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-06-302,198,275USD
At 2023-12-312,912,461USD
At 2023-06-3015,920USD
At 2022-12-31128,149USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3063,705,035USD
At 2023-12-3183,250,101USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-06-30762,877USD
At 2023-12-31831,656USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-06-30667,512USD
At 2023-12-31622,714USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,304,538USD91
2024-01-01 to 2024-06-30-6,857,700USD182
2023-04-01 to 2023-06-30-5,308,952USD91
2023-01-01 to 2023-06-30-7,137,667USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-6,857,700USD182
2023-01-01 to 2023-06-30-7,137,667USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,304,538USD91
2024-01-01 to 2024-06-30-6,575,497USD182
2023-04-01 to 2023-06-30-5,624,429USD91
2023-01-01 to 2023-06-30-7,764,312USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-04-01 to 2024-06-3023,530USD91
2024-01-01 to 2024-06-3047,061USD182
2023-04-01 to 2023-06-3026,274USD91
2023-01-01 to 2023-06-3050,375USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-04-01 to 2024-06-3019,771USD91
2024-01-01 to 2024-06-3028,825USD182
2023-04-01 to 2023-06-30-461USD91
2023-01-01 to 2023-06-3034,080USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-2,113,051USD91
2024-01-01 to 2024-06-30-4,285,868USD182
2023-04-01 to 2023-06-30-3,821,568USD91
2023-01-01 to 2023-06-30-4,375,412USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-01-01 to 2024-06-3014,830USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-06-302,687,225USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30113,872USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-321,816USD182
2023-01-01 to 2023-06-30599,520USD181

Inspect the source

Entity
Longevity Health Holdings, Inc. / CIK 0001842939
Captured
2026-09-21T17:37:49.979Z
SEC response SHA-256
33db7095b2d5ec482c7a1d00924c3102d456f2ff5cede2f410122a82954c4d25

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001842939.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))